Cite

HARVARD Citation

    Elhadad, S. et al. (2023). Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies. Thrombosis research. pp. 47-56. [Online]. 
  
Back to record